(Q71774484)

English

Management of the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) study after the Scandinavian Simvastatin Survival Study (4S)

scientific article published on 01 September 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Management of the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) study after the Scandinavian Simvastatin Survival Study (4S) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

based on heuristic

inferred from title

author name string

A M Tonkin

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

language of work or name

0 references

publication date

1 September 1995

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

American Journal of Cardiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

76

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

107C-112C

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Cholesterol lowering and mortality: the importance of considering initial level of risk

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

The value of lowering cholesterol after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. Harvard Atherosclerosis Reversibility Project (HARP) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

Decreased in vitro oxidizability of low-density lipoprotein in hypercholesterolaemic patients treated with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: quantitative angiographic observations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

Effects of long-term treatment with lovastatin on the clotting system and blood platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

Long-term prognosis after recovery from myocardial infarction: a nine year follow-up of the Perth Coronary Register

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

After the meta-analyses: a commentary on treatment of dyslipidaemia in the primary prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980479-2

7 January 2021

Identifiers

10.1016/S0002-9149(99)80479-2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71774484&oldid=1831401326"